Cases & Deals

Faron Pharmaceuticals places €3.1 million of Ordinary Shares on AIM

Clients Faron Pharmaceuticals Oy

Jones Day represented Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection its €3.1 million (US$3.5 million) placement of Ordinary Shares on the Alternative Investment Market (AIM).